Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS)

被引:35
作者
Klys, M [1 ]
Rojek, S [1 ]
Bolechala, F [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Toxicol, Inst Forens Med, Krakow, Poland
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 825卷 / 01期
关键词
trileptal; oxcarbazepine; hair; LC/APCI/MS;
D O I
10.1016/j.jchromb.2005.02.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A typical use of hair analysis in forensic toxicology is the documentation of previous drug administration. This is illustrated in a suicidal death of a 58-year-old epileptic patient who was treated with oxcarbazepine and probably with levomepromazine. The toxicological analysis carried out by HPLC/APCI/MS included also the hair (6 cm length) besides postmortem blood. The method was validated for levomepromazine, oxcarbazepine (OXCBZ) and its two metabolites, 10-hydroxycarbazepine (CBZ-10OH) and trans-diol-carbazepine (CBZ-diOH) in various biological matrices. The analysis of the postmortem blood indicated oxcarbazepine and its two main metabolites were present at therapeutic concentrations; levomepromazine was detected at a fatal concentration. In three 2-cm segments of hair, oxcarbazepine and its two metabolites were detected; however, levomepromazine was not detected in this specimen. As a result of complex chemical-toxicological investigation it was confirmed the information that the decedent was an epileptic patient and was treated with oxcarbazepine for at least 6 months before death. In addition, he took a toxic dose of levomepromazine in order to commit suicide. The analysis revealed differences between the concentration levels of oxcarbazepine and its active metabolite CBZ-10OH in postmortem specimens and hair, suggesting different mechanisms of penetration of metabolites and their precursors into this matrix. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 23 条
[1]  
[Anonymous], 1995, DISPOSITION TOXIC DR
[2]   Determination of antiepileptic drugs in biological material [J].
Chollet, DF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 767 (02) :191-233
[3]   Testing hair for pharmaceuticals [J].
Gaillard, Y ;
Pépin, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 733 (1-2) :231-246
[4]   Validated method for the simultaneous determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization [J].
Gustafson, RA ;
Moolchan, ET ;
Barnes, A ;
Levine, B ;
Huestis, MA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 798 (01) :145-154
[5]   METABOLISM OF LEVOMEPROMAZINE IN MAN [J].
HALS, PA ;
DAHL, SG .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (01) :61-71
[6]  
ISHIYAMA I, 1983, J FORENSIC SCI, V28, P380
[7]   Oxcarbazepine, an antiepileptic agent [J].
Kalis, MM ;
Huff, NA .
CLINICAL THERAPEUTICS, 2001, 23 (05) :680-700
[8]   DETECTION OF DRUGS IN HUMAN HAIR FOR CLINICAL AND FORENSIC APPLICATIONS [J].
KINTZ, P ;
TRACQUI, A ;
MANGIN, P .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 1992, 105 (01) :1-4
[9]   Postmortem toxicology of carbamazepine [J].
Klys, M ;
Bystrowska, B ;
Bujak-Gizycka, B .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (04) :243-248
[10]  
KLYS M, 2000, B TIAFT HELNS, V2, P240